The Breast Cancer Monitoring Panel can help your healthcare provider monitor breast cancer treatment and therapy.
Both the CA 15‐3 and CA 27.29 are proteins that are normally produced by breast cells. In persons with breast cancer, the levels can increase. The protein amounts can rise with breast cancer tumor growth and fall with treatment.
The carcinoembryonic antigen is a protein that may be present in people with cancer, including breast cancer. The CEA Test measures the amount of this protein in your blood. CEA is normally detected in healthy adults, but at a certain range (see below Normal Range).
These three tests can also help your healthcare provider offer a more accurate prognosis (or prediction of your health).
TEST DETAILS
The Breast Cancer Monitoring Panel includes the following tests:
- CA 15‐3
- CA 27‐29
- CEA
FAQS
"This content is for educational purposes and does not substitute personalized medical advice."
Quentin Caswell, MSN, is an Integrative and Functional Medicine Specialist dedicated to helping patients feel their best. Board certified in advanced bioidentical hormone replacement and peptide therapy, he earned his Master of Science in Nursing from the University of Missouri (Mizzou) and opened Advanced Practice Wellness Clinic in 2011.